Kurtzman; Gary J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kurtzman; Gary J..The latest application filed is for "methods of treating anemia using recombinant adeno-associated virus virions".

Company Profile

0.15.16

Kurtzman; Gary J. - Bryn Mawr PA
Kurtzman; Gary J. - Menlo Park CA
Kurtzman; Gary J. - Valanava PA
Kurtzman, Gary J. - Villanova PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods of treating anemia using recombinant adeno-associated virus virions Grant 7,829,078 - Podsakoff , et al. November 9, 2	2010-11-09
Methods of treating anemia using recombinant adeno-associated virus virions App 20100104535 - Podsakoff; Gregory M. ; et al.	2010-04-29
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions Grant 7,704,492 - Podsakoff , et al. April 27, 2	2010-04-27
Methods of treating anemia using recombinant adeno-associated virus virions App 20090208459 - Podsakoff; Gregory M. ; et al.	2009-08-20
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions App 20080305084 - Podsakoff; Gregory M. ; et al.	2008-12-11
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors App 20080199442 - Podsakoff; Gregory M. ; et al.	2008-08-21
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions vectors App 20080069803 - Podsakoff; Gregory M. ; et al.	2008-03-20
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors Grant 7,238,674 - Podsakoff , et al. July 3, 2	2007-07-03
Induction of immune response to antigens expressed by recombinant adeno-associated virus App 20060216274 - Kurtzman; Gary J. ; et al.	2006-09-28
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions vectors App 20060099184 - Podsakoff; Gregory M. ; et al.	2006-05-11
Methods of treating anemia using recombinant adeno-associated virus virions App 20060099185 - Podsakoff; Gregory M. ; et al.	2006-05-11
Induction of immune response to antigens expressed by recombinant adeno-associated virus App 20040161409 - Kurtzman, Gary J. ; et al.	2004-08-19
Induction of immune response to antigens expressed by recombinant adeno-associated virus Grant 6,710,036 - Kurtzman , et al. March 23, 2	2004-03-23
Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors App 20030223971 - Kurtzman, Gary J. ; et al.	2003-12-04
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions App 20030219415 - Podsakoff, Gregory M. ; et al.	2003-11-27
Methods of treating anemia using recombinant adeno-associated virus virions App 20030206889 - Podsakoff, Gregory M. ; et al.	2003-11-06
Adeno associated virus vectors for the treatment of a cardiomyopathy Grant 6,610,290 - Podsakoff , et al. August 26, 2	2003-08-26
Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors Grant 6,531,456 - Kurtzman , et al. March 11, 2	2003-03-11
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions App 20020155608 - Podsakoff, Gregory M. ; et al.	2002-10-24
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors App 20020147172 - Podsakoff, Gregory M. ; et al.	2002-10-10
Induction of immune response to antigens expressed by recombinant adeno-associated virus App 20020102243 - Kurtzman, Gary J. ; et al.	2002-08-01
Methods for delivering DNA to the bloodstream using recombinant adeno-associated virus vectors Grant 6,391,858 - Podsakoff , et al. May 21, 2	2002-05-21
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions to treat lysosomal storage disease Grant 6,335,011 - Podsakoff , et al. January 1, 2	2002-01-01
Methods of treating disease using recombinant adeno-associated virus virions administered to muscle Grant 6,325,998 - Podsakoff , et al. December 4, 2	2001-12-04
Methods for delivering DNA to the bloodstream using recombinant adeno-associated virus vectors App 20010001661 - Podsakoff, Gregory M. ; et al.	2001-05-24
Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors Grant 6,218,180 - Kurtzman , et al. April 17, 2	2001-04-17
Methods for delivering DNA to the bloodstream using recombinant adeno-associated virus vectors Grant 6,211,163 - Podsakoff , et al. April 3, 2	2001-04-03
Adeno-associated virus vectors comprising a gene encoding a lyosomal enzyme Grant 5,962,313 - Podsakoff , et al. October 5, 1	1999-10-05
Adeno-associated virus vectors comprising a first and second nucleic acid sequence Grant 5,952,221 - Kurtzman , et al. September 14, 1	1999-09-14
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors Grant 5,858,351 - Podsakoff , et al. January 12, 1	1999-01-12
Treating anemia using recombinant adeno-associated virus virions comprising an EPO DNA sequence Grant 5,846,528 - Podsakoff , et al. December 8, 1	1998-12-08

Company Registrations

SEC

0001487934

Kurtzman Gary J

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.